Stay updated with breaking news from Oderick Turner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Long-awaited clinical trial data show psychedelic drug is effective at treating post-traumatic stress disorder in a diversity of people. Long-awaited clinical trial data show psychedelic drug is effective at treating post-traumatic stress disorder in a diversity of people.
In trials, the antipsychotic drug brexpiprazole (Rexulti) failed to provide a clinically meaningful benefit and increased the risk of death. Yet the US Food and Drug Administration (FDA) has fast tracked its approval, making Rexulti the first antipsychotic for treating agitation in elderly patients with dementia.
In trials, brexpiprazole failed to provide a clinically meaningful benefit and it increased mortality, but the FDA fast tracked its approval and the sponsor predicts $1bn in annual sales. Robert Whitaker investigates the first licensed antipsychotic for treating agitation in elderly patients with dementia For years, health officials have tried to rein in the prescribing of atypical antipsychotics to elderly patients with dementia. The practice has been entirely “off label” yet widespread. The US Food and Drug Administration reports that around 60% of patients with Alzheimer’s dementia in...
Looking back, these men reveal some of the missteps they made and the regrets they have.
Peter Gøtzsche discusses how depression pills don’t work for children and increase their risk of suicide, including fluoxetine.